Publications by authors named "David P vanMaanen"

Background: Several large trials have employed age or clinical features to select patients for atrial fibrillation (AF) screening to reduce strokes. We hypothesized that a machine learning (ML) model trained to predict AF risk from 12‑lead electrocardiogram (ECG) would be more efficient than criteria based on clinical variables in indicating a population for AF screening to potentially prevent AF-related stroke.

Methods: We retrospectively included all patients with clinical encounters in Geisinger without a prior history of AF.

View Article and Find Full Text PDF

Use of machine learning (ML) for automated annotation of heart structures from echocardiographic videos is an active research area, but understanding of comparative, generalizable performance among models is lacking. This study aimed to (1) assess the generalizability of five state-of-the-art ML-based echocardiography segmentation models within a large Geisinger clinical dataset, and (2) test the hypothesis that a quality control (QC) method based on segmentation uncertainty can further improve segmentation results. Five models were applied to 47,431 echocardiography studies that were independent from any training samples.

View Article and Find Full Text PDF

Cardiometabolic diseases are the leading cause of death worldwide. Despite a known genetic component, our understanding of these diseases remains incomplete. Here, we analyzed the contribution of rare variants to 57 diseases and 26 cardiometabolic traits, using data from 200,337 UK Biobank participants with whole-exome sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • Atrial fibrillation (AF) can lead to serious health issues if not detected early, and the study aims to use a deep neural network to predict new-onset AF from resting 12-lead ECGs in patients without a previous AF history.
  • Researchers analyzed 1.6 million ECG traces from 430,000 patients, achieving good predictive performance with an area under the receiver operating characteristic curve of 0.85, indicating an effective ability to identify those at risk for AF within a year.
  • The model also demonstrated that it could indicate a high risk for AF-related strokes, successfully identifying 62% of patients who experienced such strokes within three years, thereby highlighting the potential for targeted screening strategies.
View Article and Find Full Text PDF

Machine learning promises to assist physicians with predictions of mortality and of other future clinical events by learning complex patterns from historical data, such as longitudinal electronic health records. Here we show that a convolutional neural network trained on raw pixel data in 812,278 echocardiographic videos from 34,362 individuals provides superior predictions of one-year all-cause mortality. The model's predictions outperformed the widely used pooled cohort equations, the Seattle Heart Failure score (measured in an independent dataset of 2,404 patients with heart failure who underwent 3,384 echocardiograms), and a machine learning model involving 58 human-derived variables from echocardiograms and 100 clinical variables derived from electronic health records.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates using a deep neural network (DNN) to predict 1-year all-cause mortality from electrocardiogram (ECG) voltage-time data collected over 34 years.
  • The DNN was trained on over 1.1 million ECGs from nearly 253,400 patients, achieving a high accuracy (AUC of 0.88) in predicting mortality, even among patients whose ECGs were deemed 'normal' by doctors.
  • Results indicate that the DNN can uncover significant prognostic insights that may not be apparent to cardiologists, with a notable hazard ratio of 9.5 for predicting 1-year mortality.
View Article and Find Full Text PDF

Since the original formulation of the dopamine hypothesis, a number of other cellular-level abnormalities--eg, NMDA receptor hypofunction, GABA system dysfunction, neural connectivity disturbances--have been identified in schizophrenia, but the manner in which these potentially interact with hyperdopaminergia to lead to schizophrenic symptomatology remains uncertain. Previously, we created a neuroanatomically detailed, biophysically realistic computational model of hippocampus in the control (unaffected) and schizophrenic conditions, implemented on a 72-processor supercomputer platform. In the current study, we apply the effects of dopamine (DA), dose-dependently, to both models on the basis of an exhaustive review of the neurophysiologic literature on DA's ion channel and synaptic level effects.

View Article and Find Full Text PDF

A large number of cellular level abnormalities have been identified in the hippocampus of schizophrenic subjects. Nonetheless, it remains uncertain how these pathologies interact at a system level to create clinical symptoms, and this has hindered the development of more effective antipsychotic medications. Using a 72-processor supercomputer, we created a tissue level hippocampal simulation, featuring multicompartmental neuron models with multiple ion channel subtypes and synaptic channels with realistic temporal dynamics.

View Article and Find Full Text PDF